Rapid identification of microorganisms in medical microbiology can be of great value for selection of ideal treatments for patients for infections caused by bacteria, viruses, fungus, mycobacterium, and parasites. It enables actual reduction from conventional broad spectrum antimicrobial agents to specific targeted antimicrobial therapy. The various advantages associated with medical microbiology testing technologies over conventional manual systems, such as automated microscopy and serological testing have been the primary growth drivers for the global medical microbiology testing technologies market.
This 210 page report gives readers a comprehensive overview of the Medical Microbiology Testing Technologies Market. Browse through 30 data tables and 121 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/microbiology-testing-technologies-market.html
Europe to Lead the Pack as Uptake of Technology Improves
Geographically, this global medical microbiology testing technologies market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The report suggests that Europe and North America will offer the global market lucrative opportunities in the near future. Europe is estimated to dominate the global market as the regional market expands at a CAGR of 4.8% between 2016 and 2024. The growing demand for improved microbiology technologies in the region is expected to boost the demand in the coming years.
On the basis of indication, the global market for medical microbiology testing technologies is categorized into respiratory diseases, neurological diseases, infectious diseases, and others. Of all these segments, the infectious diseases segment is expected to acquire a share of 41% in the global market by the end of 2024 in terms of volume. The high incidence of infectious diseases across the globe is expected to drive this segment in the near future.
Increasing Government Investments Boost Global Market
The growing government investments in the research of life sciences and biological and medical sciences are largely responsible for the accelerated pace of growth of the overall market. The report predicts that government investments are likely to continue in the coming years as this research is characterized by high risk and long duration, which makes it unattractive for companies looking to make quick profits. The market is also expected to be driven by the high prevalence of infectious diseases and emerging infectious diseases, especially among the population of the developing nations. The commonly seen infectious diseases affecting individuals across the globe are impetigo, urinary tract infections, and pneumonia. Furthermore, the growing demand for automation in medical microbiology for specimen management, nucleic acid amplification, identification, microbial detection, and susceptibility testing is also estimated to benefit the global market.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Medical Microbiology Testing Technologies Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11603
High Costs and Complex Procedures Restrain Global Market
The global medical microbiology testing technologies market is being restrained by the high cost associated with various types of media. Analysts anticipate that the global market will also be held back due to the complexities involved in sample preparation techniques. The premium pricing of using medical microbiology technologies are also projected to limit the growth of the global market through the forecast period. Lastly, the impact of point-of-care testing is also proving to be a negative one on the overall market.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
No comments:
Post a Comment